1. Home
  2. STKL vs IMNM Comparison

STKL vs IMNM Comparison

Compare STKL & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STKL
  • IMNM
  • Stock Information
  • Founded
  • STKL 1973
  • IMNM 2006
  • Country
  • STKL United States
  • IMNM United States
  • Employees
  • STKL N/A
  • IMNM N/A
  • Industry
  • STKL Precious Metals
  • IMNM Medicinal Chemicals and Botanical Products
  • Sector
  • STKL Basic Materials
  • IMNM Health Care
  • Exchange
  • STKL Nasdaq
  • IMNM Nasdaq
  • Market Cap
  • STKL 631.4M
  • IMNM 542.6M
  • IPO Year
  • STKL N/A
  • IMNM 2020
  • Fundamental
  • Price
  • STKL $3.90
  • IMNM $7.91
  • Analyst Decision
  • STKL Strong Buy
  • IMNM Strong Buy
  • Analyst Count
  • STKL 2
  • IMNM 6
  • Target Price
  • STKL $9.50
  • IMNM $26.00
  • AVG Volume (30 Days)
  • STKL 1.1M
  • IMNM 1.7M
  • Earning Date
  • STKL 05-07-2025
  • IMNM 05-13-2025
  • Dividend Yield
  • STKL N/A
  • IMNM N/A
  • EPS Growth
  • STKL N/A
  • IMNM N/A
  • EPS
  • STKL N/A
  • IMNM N/A
  • Revenue
  • STKL $723,728,000.00
  • IMNM $9,041,000.00
  • Revenue This Year
  • STKL $9.79
  • IMNM N/A
  • Revenue Next Year
  • STKL $7.58
  • IMNM $1,259.12
  • P/E Ratio
  • STKL N/A
  • IMNM N/A
  • Revenue Growth
  • STKL 15.48
  • IMNM N/A
  • 52 Week Low
  • STKL $3.65
  • IMNM $5.15
  • 52 Week High
  • STKL $8.11
  • IMNM $19.07
  • Technical
  • Relative Strength Index (RSI)
  • STKL 28.21
  • IMNM 55.28
  • Support Level
  • STKL $3.65
  • IMNM $6.96
  • Resistance Level
  • STKL $4.22
  • IMNM $7.56
  • Average True Range (ATR)
  • STKL 0.23
  • IMNM 0.69
  • MACD
  • STKL 0.03
  • IMNM 0.26
  • Stochastic Oscillator
  • STKL 19.53
  • IMNM 98.22

About STKL SunOpta Inc.

SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for leading natural and private label brands and also produces its own propriety brands, including SOWN, Dream and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: